33 phenotypes from 3 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Badtm1Meg/Badtm1Meg involves: 129S4/SvJae	abnormal apoptosis	J:88139
	abnormal B cell differentiation	J:88139
	abnormal body weight	J:133563
	abnormal T cell differentiation	J:88139
	decreased circulating insulin level	J:133563
	decreased insulin secretion	J:133563
	decreased mature B cell number	J:88139
	decreased pro-B cell number	J:88139
	decreased thymus weight	J:88139
	increased circulating glucose level	J:133563
	increased pancreatic beta cell apoptosis	J:133563
	small pancreatic islets	J:133563
	small thymus	J:88139
	thymus hypoplasia	J:88139
Badtm1Sjk/Badtm1Sjk B6.129X1-Badtm1Sjk	abnormal hippocampus morphology	J:111236
	gliosis	J:111236
Badtm1Sjk/Badtm1Sjk either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6)	abnormal apoptosis	J:84987
	abnormal B cell physiology	J:84987
	abnormal immune system cell morphology	J:84987
	abnormal reproductive system morphology	J:84987
	abnormal T cell physiology	J:84987
	abnormal testis morphology	J:84987
	increased B cell derived lymphoma incidence	J:84987
	increased cellular sensitivity to gamma-irradiation	J:84987
	increased lymphoma incidence	J:84987
	increased tumor incidence	J:84987
	multinucleated giant male germ cells	J:84987
	premature death	J:84987
Badtm1Sjk/Badtm1Sjk involves: 129X1/SvJ	abnormal circulating glucose level	J:133563
	abnormal pancreatic beta cell physiology	J:133563
	decreased insulin secretion	J:133563
	normal immune system phenotype	J:132819
	increased circulating insulin level	J:133563
	increased pancreatic islet number	J:133563
Badtm2Meg/Badtm2Meg involves: 129S4/SvJae * C57BL/6 * SJL	decreased insulin secretion	J:133563
	impaired glucose tolerance	J:133563